Literature DB >> 1327751

Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.

T Crook1, K H Vousden.   

Abstract

Primary human papillomavirus (HPV) positive anogenital cancers normally develop without somatic mutation within the p53 gene. In this study, however, we have identified p53 point mutations in metastases arising from HPV positive cervical carcinomas, suggesting that acquisition of p53 mutation may play a role in the progression of some HPV associated primary cancers. p53 mutants identified in anogenital cancers exhibit a dominant transforming phenotype and increased resistance to HPV16 E6 directed degradation. The association of p53 mutation with metastases may explain the poor prognosis reported for HPV negative primary cancers, many of which already contain mutant p53. A high proportion of p53 mutations detected in both primary and metastatic cancers are GC-->TA transversions, strongly suggesting a role for external carcinogens in the development of these cancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327751      PMCID: PMC556904          DOI: 10.1002/j.1460-2075.1992.tb05487.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  41 in total

1.  Carcinogens leave fingerprints.

Authors:  B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

2.  Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.

Authors:  G Shaulsky; N Goldfinger; V Rotter
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

3.  Progression of human papillomavirus type 18-immortalized human keratinocytes to a malignant phenotype.

Authors:  P J Hurlin; P Kaur; P P Smith; N Perez-Reyes; R A Blanton; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 4.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

5.  Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.

Authors:  T Crook; D Wrede; J Tidy; J Scholefield; L Crawford; K H Vousden
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

Review 6.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

7.  Clonal expansion of p53 mutant cells is associated with brain tumour progression.

Authors:  D Sidransky; T Mikkelsen; K Schwechheimer; M L Rosenblum; W Cavanee; B Vogelstein
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

8.  Temperature-sensitive mutants of p53 associated with human carcinoma of the lung.

Authors:  E A Medcalf; T Takahashi; I Chiba; J Minna; J Milner
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

9.  p53 is frequently mutated in Burkitt's lymphoma cell lines.

Authors:  P J Farrell; G J Allan; F Shanahan; K H Vousden; T Crook
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

10.  p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.

Authors:  T Unger; M M Nau; S Segal; J D Minna
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  33 in total

1.  Integrity of the N-terminal transcription domain of p53 is required for mutant p53 interference with drug-induced apoptosis.

Authors:  D Matas; A Sigal; P Stambolsky; M Milyavsky; L Weisz; D Schwartz; N Goldfinger; V Rotter
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination.

Authors:  R V Sionov; S Coen; Z Goldberg; M Berger; B Bercovich; Y Ben-Neriah; A Ciechanover; Y Haupt
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance.

Authors:  Heidi Sankala; Catherine Vaughan; Jing Wang; Sumitra Deb; Paul R Graves
Journal:  Arch Biochem Biophys       Date:  2011-05-20       Impact factor: 4.013

4.  Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

Authors:  M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1997-01       Impact factor: 4.272

Review 5.  Human papillomaviruses and cervical neoplasia. II. Interaction of HPV with other factors.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

6.  Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix.

Authors:  C S Herrington; M Worsham; S A Southern; P Mackowiak; S R Wolman
Journal:  Mol Pathol       Date:  2001-06

7.  HPV and p53 in cervical cancer.

Authors:  H Y Ngan; M Stanley; S S Liu; H K Ma
Journal:  Genitourin Med       Date:  1994-06

8.  Expression of p53 protein related to human papillomavirus and DNA ploidy in superficial esophageal carcinoma.

Authors:  T Nakamura; H Ide; R Eguchi; K Hayashi; F Hanyu; K Nagasako; M Yukawa; K Asaka; T Fujimori; S Maeda
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9.

Authors:  Jacqueline L Y Chee; Suzan Saidin; David P Lane; Sai Mun Leong; Jacqueline E Noll; Paul M Neilsen; Yi Ting Phua; Hani Gabra; Tit Meng Lim
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

10.  Transforming properties of the cottontail rabbit papillomavirus oncoproteins Le6 and SE6 and of the E8 protein.

Authors:  J B Harry; F O Wettstein
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.